Brainsway Ltd (BWAY) Stock Analysis

Sector: HEALTHCARE - MEDICAL DEVICES

Exchange: NASDAQ

Key Metrics

• Price: $23.41
• Market Cap: $493.98M
• P/E Ratio: 76.41
• EPS: $0.32
• 52-Week High: $26.63
• 52-Week Low: $7.84

Market Sentiment

Brainsway Ltd currently has a Bullish sentiment score of 0.26.

About Brainsway Ltd

Brainsway Ltd. is a pioneering medical device company focused on developing non-invasive neuromodulation therapies for neurological and psychiatric disorders. Headquartered in Jerusalem, Israel, the company leverages its proprietary Deep TMS (Transcranial Magnetic Stimulation) technology to address significant unmet medical needs globally. Brainsway's strong commitment to research and development, paired with an innovative approach, positions it as a leader in the neuromodulation sector, driv...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Brainsway Ltd and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does BWAY pay dividends?

Brainsway Ltd (BWAY) does not currently pay a regular dividend.

What is BWAY's P/E ratio?

Brainsway Ltd has a price-to-earnings (P/E) ratio of 76.41.

What is BWAY's market cap?

Brainsway Ltd (BWAY) has a market capitalization of $493.98M with a current stock price of $23.41.